2020 -- H 7817

========

LC004956

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2020

____________

A N   A C T

RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

     

     Introduced By: Representative Thomas E. Noret

     Date Introduced: February 26, 2020

     Referred To: House Health, Education & Welfare

     It is enacted by the General Assembly as follows:

1

     SECTION 1. Section 21-28-2.08 of the General Laws in Chapter 21-28 entitled "Uniform

2

Controlled Substances Act" is hereby amended to read as follows:

3

     21-28-2.08. Contents of schedules.

4

     Schedule I

5

     (a) Schedule I shall consist of the drugs and other substances, by whatever official name,

6

common or usual name, chemical name, or brand name designated, listed in this section.

7

     (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the

8

following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers

9

whenever the existence of the isomers, esters, ethers, and salts is possible within the specific

10

chemical designation:

11

     (1) Acetylmethadol

12

     (2) Allylprodine

13

     (3) Alphacetylmethadol

14

     (4) Alphameprodine

15

     (5) Alphamethadol

16

     (6) Benzethidine

17

     (7) Betacetylmethadol

18

     (8) Betameprodine

19

     (9) Betamethadol

 

1

     (10) Betaprodine

2

     (11) Clonitazene

3

     (12) Dextromoramide

4

     (13) Difenoxin

5

     (14) Diampromide

6

     (15) Diethylthiambutene

7

     (16) Dimenoxadol

8

     (17) Dimepheptanol

9

     (18) Dimethylthiambutene

10

     (19) Dioxaphetyl butyrate

11

     (20) Dipipanone

12

     (21) Ethylmethylthiambutene

13

     (22) Etonitazene

14

     (23) Extoxerdine

15

     (24) Furethidine

16

     (25) Hydroxypethidine

17

     (26) Ketobemidone

18

     (27) Levomoramide

19

     (28) Levophenacylmorphan

20

     (29) Morpheridine

21

     (30) Noracymethadol

22

     (31) Norlevorphanol

23

     (32) Normethadone

24

     (33) Norpipanone

25

     (34) Phenadoxone

26

     (35) Phenampromide

27

     (36) Phenomorphan

28

     (37) Phenoperidine

29

     (38) Piritramide

30

     (39) Proheptazine

31

     (40) Properidine

32

     (41) Propiram

33

     (42) Racemoramide

34

     (43) Trimeperidone

 

LC004956 - Page 2 of 18

1

     (44) Tilidine

2

     (45) Alpha-methylfentanyl

3

     (46) Beta-hydroxy-3-methylfentanyl other names:

4

     N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl]- Nphenylpropanamide

5

     (47) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-

6

phenylpropanamide)

7

     (48) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its optical, positional, and

8

geometric isomers, salts and salts of isomers (Other names: acetyl fentanyl)

9

     (49) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] piperidin-4-yl]-N-phenyl propionamide

10

(Other names: beta-hydroxythiofentanyl)

11

     (50) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide (Other names: Butyryl fentanyl)

12

     (51) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (Other names: Furanyl

13

fentanyl)

14

     (52) 3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl] benzamide (Other names:

15

AH-7921)

16

     (53) 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (Other names:

17

U-47700)

18

     (54) 3-Methylbutyrfentanyl (Other names: 3-MBF)

19

     (55) 4-Fluorobutyrfentanyl (Other names: 4-FBF, p-FBF)

20

     (56) 4-Phenylfentanyl

21

     (57) 4-Methoxybutyrfentanyl (Other names: 4-MeO-BF)

22

     (58) Acrylfentanyl (Other names: acryloyfentanyl)

23

     (59) Lofentanyl

24

     (60) N-Methylcarfentanyl

25

     (61) Ocfentanyl (INN, A-3217)

26

     (63) 4-methoxymethylfentanyl (Other names: R-30490)

27

     (64) 1-cyclohexyl-4-(1,2 diphenylethyl)piperazine) (Other names: MT-45, IC-6)

28

     (c) Opium Derivatives. Unless specifically excepted or unless listed in another schedule,

29

any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the

30

existence of the salts, isomers, and salts of isomers is possible within the specific chemical

31

designation:

32

     (1) Acetorphine

33

     (2) Acetyldihydrocodeine

34

     (3) Benzylmorphine

 

LC004956 - Page 3 of 18

1

     (4) Codeine methylbromide

2

     (5) Codeine-N-Oxide

3

     (6) Cyprenorphine

4

     (7) Desomorphine

5

     (8) Dihydromorphine

6

     (9) Etorphine (Except hydrochloride salt)

7

     (10) Heroin

8

     (11) Hydromorphinol

9

     (12) Methyldesorphine

10

     (13) Methylihydromorphine

11

     (14) Morphine methylbromide

12

     (15) Morphine methylsulfonate

13

     (16) Morphine-N-Oxide

14

     (17) Myrophine

15

     (18) Nococodeine

16

     (19) Nicomorphine

17

     (20) Normorphine

18

     (21) Pholcodine

19

     (22) Thebacon

20

     (23) Drotebanol

21

     (d) Hallucinogenic Substances. Unless specifically excepted or unless listed in another

22

schedule, any material, compound, mixture, or preparation that contains any quantity of the

23

following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers

24

whenever the existence of the salts, isomers, and salts of isomers is possible within the specific

25

chemical designation (for purposes of this subsection only, the term "isomer" includes the optical,

26

position, and geometric isomers):

27

     (1) 3, 4-methylenedioxy amphetamine

28

     (2) 5-methoxy-3, 4-methylenedioxy amphetamine

29

     (3) 3, 4, 5-trimethoxy amphetamine

30

     (4) Bufotenine

31

     (5) Diethyltryptamine

32

     (6) Dimethyltryptamine

33

     (7) 4-methyl 2, 5-dimethoxyamphetamine

34

     (8) Ibogaine

 

LC004956 - Page 4 of 18

1

     (9) Lysergic acid diethylamide

2

     (10) Marihuana

3

     (11) Mescaline

4

     (12) Peyote. Meaning all parts of the plant presently classified botanically as Lophophora

5

Williamsii Lemair whether growing or not; the seeds of the plant; any extract from any part of the

6

plant; and any compound, manufacture, salt, derivative, mixture, or preparation of the plant, its

7

seeds or extracts.

8

     (13) N-ethyl-3-piperidyl benzilate

9

     (14) N-methyl-3-piperidyl benzilate

10

     (15) Psilocybin

11

     (16) Psilocyn

12

     (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the plant,

13

or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their

14

isomers with similar chemical structure and pharmacological activity such as the following: delta

15

1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans

16

tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and

17

their optical isomer. (Since nomenclature of these substances is not internationally standardized,

18

compounds of these structures, regardless of numerical designation of atomic positions covered).

19

     (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-

20

Thienyl analog of phencyclidine: TPCP

21

     (19) 2,5 dimethoxyamphetamine

22

     (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha-

23

methylphenethyamine: 4-bromo-2,5-DMA

24

     (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine:

25

paramethoxyamphetamine: PMA

26

     (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1-

27

phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE

28

     (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP

29

     (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-

30

trimethyl-6H-dibenz o (b,d) pyran: Synhexyl.

31

     (25) Salvia Divinorum (Salvinorin A or Divinorin A), meaning any extract from any part

32

of the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall

33

not mean the unaltered plant.

34

     (26) Datura stamonium (jimsom weed or datura), meaning any extract from any part of the

 

LC004956 - Page 5 of 18

1

plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall not mean

2

the unaltered plant.

3

     (e) Depressants. Unless specifically excepted or unless listed in another schedule, any

4

material, compound, mixture, or preparation that contains any quantity of the following substances

5

having a depressant effect on the central nervous system, including its salts, isomers, and salts of

6

isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the

7

specific chemical designation:

8

     (1) Mecloqualone.

9

     (2) Methaqualone.

10

     (3) 3-methyl fentanyl (n-(3methyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

11

     (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional, and geometric

12

isomers, salts, and salts of isomers.

13

     (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts, and salts

14

of isomers.

15

     (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts,

16

and salts of isomers.

17

     (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha-

18

methylfentanyl), its optical isomers, salts, and salts of isomers.

19

     (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-

20

methylthiofentanyl), its optical isomers, salts, and salts of isomers.

21

     (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers,

22

salts, and salts of isomers.

23

     (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-

24

hydroxyfentanyl), its optical isomers, salts, and salts of isomers.

25

     (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-

26

hydroxy-3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers.

27

     (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3-

28

methylthiofentanyl), its optical and geometric isomers, salts, and salts of isomers.

29

     (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its

30

optical isomers, salts, and salts of isomers.

31

     (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical

32

isomers, salts, and salts of isomers.

33

     (15) N-[1-(2-phenylethyl)-4-piperidyl]-N-(4-fluorophenyl)-propanamid e (para-

34

fluorofentanyl), its optical isomers, salts, and salts of isomers.

 

LC004956 - Page 6 of 18

1

     (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or

2

geometric isomers, salts, and salts of isomers.

3

     (f) Stimulants. Unless specifically excepted or unless listed in another schedule, any

4

material, compound, mixture, or preparation that contains any quantity of the following substances

5

having a stimulant effect on the central nervous system, including its salts, isomers, and salts of

6

isomers:

7

     (1) Fenethylline

8

     (2) N-ethylamphetamine

9

     (3) 4-methyl-N-methylcathinone (Other name: mephedrone)

10

     (4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone)

11

     (5) 3,4-methylenedioxypyrovalerone (Other name: MDPV)

12

     (g) Any material, compound, mixture, or preparation that contains any quantity of the

13

following substances:

14

     (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497)

15

     (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol

16

(cannabicyclohexanol and CP-47,497 c8 homologue)

17

     (3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073)

18

     (4) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)

19

     (5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678)

20

     (h) Synthetic cannabinoids or piperazines. Unless specifically excepted, any chemical

21

compound which is not approved by the United States Food and Drug Administration or, if

22

approved, which is not dispensed or possessed in accordance with state and federal law, that

23

contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine (TFMPP); 1,1-

24

Dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210); 1-Butyl-3-(1-naphthoyl) indole; 1-

25

Pentyl-3-(1-naphthoyl) indole; dexanabinol (HU-211); or any compound in the following structural

26

classes:

27

     (1) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with

28

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

29

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

30

group, whether or not further substituted in the indole ring to any extent and whether or not

31

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

32

limited, to JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, and AM-

33

2201;

34

     (2) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure with

 

LC004956 - Page 7 of 18

1

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

2

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

3

group whether or not further substituted in the indole ring to any extent and whether or not

4

substituted in the phenyl ring to any extent. Examples of this structural class include, but are not

5

limited to, JWH-167, JWH-250, JWH-251, and RCS-8;

6

     (3) Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with

7

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

8

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

9

group whether or not further substituted in the indole ring to any extent and whether or not

10

substituted in the phenyl ring to any extent. Examples of this structural class include, but are not

11

limited, to AM-630, AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4;

12

     (4) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol

13

structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl,

14

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

15

group whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural

16

class include, but are not limited to, CP 47,497 and its C8 homologue (cannabicyclohexanol);

17

     (5) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl)

18

methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,

19

alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-

20

morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and

21

whether or not substituted in the naphthyl ring to any extent. Examples of this structural class

22

include, but are not limited to, JWH-175, JWH-184, and JWH-185;

23

     (6) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure with

24

substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl,

25

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

26

group whether or not further substituted in the pyrrole ring to any extent and whether or not

27

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

28

limited, to JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;

29

     (7) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl)indene

30

structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl,

31

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

32

group whether or not further substituted in the indene ring to any extent and whether or not

33

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

34

limited to, JWH-176; or

 

LC004956 - Page 8 of 18

1

     (8) Any other synthetic cannabinoid or piperazine which is not approved by the United

2

States Food and Drug Administration or, if approved, which is not dispensed or possessed in

3

accordance with state and federal law.

4

     (i) Synthetic cathinones. Unless specifically excepted, any chemical compound which is

5

not approved by the United States Food and Drug Administration or, if approved, which is not

6

dispensed or possessed in accordance with state and federal law, not including bupropion,

7

structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl,

8

naphthyl, or thiophene ring systems, whether or not the compound is further modified in one or

9

more of the following ways:

10

     (1) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy,

11

haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by

12

one or more other univalent substituents. Examples of this class include, but are not limited to, 3,4-

13

Methylenedioxycathinone (bk-MDA);

14

     (2) By substitution at the 3-position with an acyclic alkyl substituent. Examples of this

15

class include, but are not limited to, 2-methylamino-1-phenylbutan-1-one (buphedrone);

16

     (3) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or

17

methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.

18

Examples of this class include, but are not limited to, Dimethylcathinone, Ethcathinone, and α-

19

Pyrrolidinopropiophenone (α-PPP); or

20

     (4) Any other synthetic cathinone which is not approved by the United States Food and

21

Drug Administration or, if approved, is not dispensed or possessed in accordance with state or

22

federal law.

23

     Schedule II

24

     (a) Schedule II shall consist of the drugs and other substances, by whatever official name,

25

common or usual name, chemical name, or brand name designated, listed in this section.

26

     (b) Substances, vegetable origin, or chemical synthesis. Unless specifically excepted or

27

unless listed in another schedule, any of the following substances whether produced directly or

28

indirectly by extraction from substances of vegetable origin, or independently by means of

29

chemical synthesis, or by a combination of extraction and chemical synthesis:

30

     (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or

31

opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the

32

following:

33

     (i) Raw opium

34

     (ii) Opium extracts

 

LC004956 - Page 9 of 18

1

     (iii) Opium fluid extracts

2

     (iv) Powdered opium

3

     (v) Granulated opium

4

     (vi) Tincture of opium

5

     (vii) Etorphine hydrochloride

6

     (viii) Codeine

7

     (ix) Ethylmorphine

8

     (x) Hydrocodone

9

     (xi) Hydromorphone

10

     (xii) Metopon

11

     (xiii) Morphine

12

     (xiv) Oxycodone

13

     (xv) Oxymorphone

14

     (xvi) Thebaine

15

     (2) Any salt, compound, derivative, or preparation that is chemically equivalent or identical

16

with any of the substances referred to in subdivision (1) of this subsection, except that these

17

substances shall not include the isoquinoline alkaloids of opium.

18

     (3) Opium poppy and poppy straw.

19

     (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any

20

salt, compound, derivative, or preparation that is chemically equivalent or identical with any of

21

these substances, except that the substances shall not include decocainized coca leaves or extraction

22

of coca leaves, which extractions do not contain cocaine or ecgonine.

23

     (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or powder

24

form that contains the phenanthrine alkaloids of the opium poppy).

25

     (c) Opiates. Unless specifically excepted or unless listed in another schedule, any of the

26

following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters, and ethers

27

whenever the existence of the isomers, esters, ethers, and salts is possible within the specific

28

chemical designation:

29

     (1) Alphaprodine

30

     (2) Anileridine

31

     (3) Bezitramide

32

     (4) Dihydrocodeine

33

     (5) Diphenoxylate

34

     (6) Fentanyl

 

LC004956 - Page 10 of 18

1

     (7) Isomethadone

2

     (8) Levomethorphan

3

     (9) Levorphanol

4

     (10) Metazocine

5

     (11) Methadone

6

     (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

7

     (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic

8

acid

9

     (14) Pethidine

10

     (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

11

     (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

12

     (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

13

     (18) Phenaxocine

14

     (19) Piminodine

15

     (20) Racemethorphan

16

     (21) Racemorphan

17

     (22) Bulk Dextropropoxyphene (non-dosage forms)

18

     (23) Suffentanil

19

     (24) Alfentanil

20

     (25) Levoalphacetylmethadol

21

     (26) Carfentanil

22

     (27) Remifentanil

23

     (d) Stimulants. Unless specifically excepted or unless listed in another schedule, any

24

material, compound, mixture, or preparation that contains any quantity of the following substances

25

having a stimulant effect on the central nervous system:

26

     (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.

27

     (2) Methamphetamine, its salts, and salts of its isomers.

28

     (3) Phenmetrazine and its salts.

29

     (4) Methylphenidate.

30

     (e) Depressants. Unless specifically excepted or unless listed in another schedule, any

31

material, compound, mixture, or preparation that contains any quantity of the following substances

32

having a depressant effect on the central nervous system, including its salts, isomers, and salts of

33

isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the

34

specific chemical designation:

 

LC004956 - Page 11 of 18

1

     (1) Amobarbital

2

     (2) Glutethimide

3

     (3) Methyprylon

4

     (4) Pentobarbital

5

     (5) Phencyclidine

6

     (6) Secobarbital

7

     (7) Phencyclidine immediate precursors:

8

     (i) 1-phencyclohexylamine

9

     (ii) 1-piperidinocyclohexane-carbonitrile (PCC)

10

     (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some

11

other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone.

12

     Schedule III

13

     (a) Unless specifically excepted or unless listed in another schedule, any material,

14

compound, mixture, or preparation that contains any quantity of the following substances having a

15

depressant effect on the central nervous system:

16

     (1) Any substance that contains any quantity of a derivative of barbituric acid or any salt

17

of a derivative of barbituric acid.

18

     (2) Chlorhexadol

19

     (3) Lysergic acid

20

     (4) Lysergic acid amide

21

     (5) Sulfondiethylmethane

22

     (6) Sulfonethylmethane

23

     (7) Sylfonmethane

24

     (8) Any compound, mixture, or preparation containing amobarbital, secobarbital,

25

pentobarbital, or any salt of them and one or more other active medicinal ingredients that are not

26

listed in any schedule.

27

     (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or

28

any salt of any of these drugs and approved by the Food and Drug Administration for marketing

29

only as a suppository.

30

     (10) Ketamine, its salts, isomers, and salts of isomers. (Some other names for ketamine:

31

(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone).

32

     (b) Unless specifically excepted or unless listed in another schedule, any material,

33

compound, mixture, or preparation containing limited quantities of any of the following narcotic

34

drugs, or any salts of them:

 

LC004956 - Page 12 of 18

1

     (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

2

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal

3

or greater quantity of an isoquinoline alkaloid of opium.

4

     (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

5

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

6

more active, nonnarcotic ingredients in recognized therapeutic amounts.

7

     (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

8

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

9

a fourfold or greater quantity of an isoquinoline alkaloid of opium.

10

     (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

11

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

12

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

13

     (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one hundred

14

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

15

more active nonnarcotic ingredients in recognized therapeutic amounts.

16

     (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one hundred

17

milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with one or

18

more active nonnarcotic ingredients in recognized therapeutic amounts.

19

     (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred milliliters

20

(100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five milligrams (25 mgs.)

21

per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.

22

     (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters (100

23

mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in

24

recognized therapeutic amounts.

25

     (c) Stimulants. Unless specifically excepted or listed in another schedule, any material,

26

compound, mixture, or preparation that contains any quantity of the following substances having a

27

stimulant effect on the central nervous system, including its salts, isomers, and salts of the isomers

28

whenever the existence of the salts of isomers is possible within the specific chemical designation:

29

     (1) Benzphetamine

30

     (2) Chlorphentermine

31

     (3) Clortermine

32

     (4) Mazindol

33

     (5) Phendimetrazine

34

     (d) Steroids and hormones. Anabolic steroids (AS) or human growth hormone (HGH),

 

LC004956 - Page 13 of 18

1

excluding those compounds, mixtures, or preparations containing an anabolic steroid that because

2

of its concentration, preparation, mixture, or delivery system, has no significant potential for abuse,

3

as published in 21 C.F.R. § 1308.34, including, but not limited to, the following:

4

     (1) Chlorionic gonadotropin, except when used for injection of implantation in cattle or

5

any other non-human species and when that use is approved by the Food and Drug Administration.

6

     (2) Clostebol

7

     (3) Dehydrochlormethyltestosterone

8

     (4) Ethylestrenol

9

     (5) Fluoxymesterone

10

     (6) Mesterolone

11

     (7) Metenolone

12

     (8) Methandienone

13

     (9) Methandrostenolone

14

     (10) Methyltestosterone

15

     (11) Nandrolone decanoate

16

     (12) Nandrolone phenpropionate

17

     (13) Norethandrolone

18

     (14) Oxandrolone

19

     (15) Oxymesterone

20

     (16) Oxymetholone

21

     (17) Stanozolol

22

     (18) Testosterone propionate

23

     (19) Testosterone-like related compounds

24

     (20) Human Growth Hormone (HGH)

25

     (e) Hallucinogenic substances.

26

     (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in U.S.

27

Food and Drug Administration-approved drug product. (Some other names for dronabinol: (6aR-

28

trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d] pyra n-1-ol,or(-)-delta-

29

9(trans)-tetrahydrocannabinol.)

30

     Schedule IV

31

     (1) Barbital.

32

     (2) Chloral betaine

33

     (3) Chloral hydrate

34

     (4) Ethchrovynol

 

LC004956 - Page 14 of 18

1

     (5) Ethinamate

2

     (6) Methohexital

3

     (7) Meprobamate

4

     (8) Methylphenobarbital

5

     (9) Paraldehyde

6

     (10) Petrichloral

7

     (11) Phenobarbital

8

     (12) Fenfluramine

9

     (13) Diethylpropion

10

     (14) Phentermine

11

     (15) Pemoline (including organometallic complexes and chelates thereof).

12

     (16) Chlordiazepoxide

13

     (17) Clonazepam

14

     (18) Clorazepate

15

     (19) Diazepam

16

     (20) Flurazepam

17

     (21) Mebutamate

18

     (22) Oxazepam

19

     (23) Unless specifically excepted or unless listed in another schedule, any material,

20

compound, mixture, or preparation that contains any quantity of the following substances, including

21

its salts:

22

     Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2-

23

propronoxybutane).

24

     (24) Prazepam

25

     (25) Lorazepam

26

     (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25)

27

micrograms of atropine sulfate per dosage unit.

28

     (27) Pentazocine

29

     (28) Pipradrol

30

     (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane

31

     (30) Temazepam

32

     (31) Halazepam

33

     (32) Alprazolam

34

     (33) Bromazepam

 

LC004956 - Page 15 of 18

1

     (34) Camazepam

2

     (35) Clobazam

3

     (36) Clotiazepam

4

     (37) Cloxazolam

5

     (38) Delorazepam

6

     (39) Estazolam

7

     (40) Ethyl Ioflazepate

8

     (41) Fludizaepam

9

     (42) Flunitrazepam

10

     (43) Haloxazolam

11

     (44) Ketazolam

12

     (45) Loprazolam

13

     (46) Lormetazepam

14

     (47) Medazepam

15

     (48) Nimetazepam

16

     (49) Nitrazepam

17

     (50) Nordiazepam

18

     (51) Oxazolam

19

     (52) Pinazepam

20

     (53) Tetrazepam

21

     (54) Mazindol

22

     (55) Triazolam

23

     (56) Midazolam

24

     (57) Quazepam

25

     (58) Butorphanol

26

     (59) Sibutramine

27

     Schedule V

28

     (a) Any compound, mixture, or preparation containing any of the following limited

29

quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal

30

ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable

31

medicinal qualities other than those possessed by the narcotic drug alone:

32

     (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100

33

mls.) or per one hundred grams (100 gms.).

34

     (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100 milliliters

 

LC004956 - Page 16 of 18

1

(100 mls.) or per one hundred grams (100 gms.).

2

     (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100 milliliters

3

(100 mls.) or per one hundred grams (100 gms.).

4

     (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less

5

than twenty-five (25) micrograms of atropine sulfate per dosage unit.

6

     (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred milliliters

7

(100 mls.) or per one hundred grams (100 gms.).

8

     (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than twenty-

9

five (25) micrograms of atropine sulfate per dosage unit.

10

     (c) Buprenorphine

11

     (d) Unless specifically exempted or excluded or unless listed in another schedule, any

12

material, compound, mixture, or preparation that contains any quantity of the following substances

13

having a stimulant effect on the central nervous system, including its salts, isomers, and salts of

14

isomers:

15

     (1) Propylhexedrine (except as benzedrex inhaler)

16

     (2) Pyrovalerone.

17

     SECTION 2. This act shall take effect upon passage.

========

LC004956

========

 

LC004956 - Page 17 of 18

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT

***

1

     This act would exempt chlorionic gonadotropin when used for injection in cattle or any

2

non-human species when that use is approved by the Food and Drug Administration from Schedule

3

III of the Uniform Controlled Substances Act.

4

     This act would take effect upon passage.

========

LC004956

========

 

LC004956 - Page 18 of 18